Public Company NIRE 35.300.197.534
CNPJ/MF nº 60.840.055/0001-31
In compliance with CVM Instruction No. 358/02, Fleury S.A. ('Company') informs its shareholders and the market in general that, in continuity to the Material Facts published on on September 3rd, 2015 and August 6th, 2014, has concluded the sale of 100% (one hundred percent) of the capital of Cruzeiro do Sul Medicina Diagnóstica Ltda. ('Cruzeiro do Sul') to Rise do Brasil Participações Ltda. ('Rise'). The completion of the sale occurred after the accomplishment of precedent conditions, among them the sale approval by the Administrative Council for Economic Defense ('CADE').
The sale of Cruzeiro do Sul meets the established between the Company and CADE through the Performance Commitment Agreement ('TCD') signed on August 6th, 2014, for approval of the Acts of Concentration numbers: 08012.008448 / 2011-13, 08012.013191 / 2010-22 and 08012.008447 / 2011-61.
The sale corresponds to 100% (one hundred percent) of the representative shares of Cruzeiro do Sul for R$ 16,000,000.00 (sixteen million reais).
Condere acted as exclusive strategic and financial advisor for Grupo Fleury in this transaction.
São Paulo, November 5th 2015.
Adolpho C. Souza Neto
Diretor de Relações com Investidores FLEURY S.A.